2025-01-012025-12-312025-12-31false08086586KITE INSIGHTS LIMITED2026-04-23falseiso4217:GBPxbrli:pure080865862024-12-31080865862025-12-31080865862025-01-012025-12-31080865862023-12-31080865862024-12-31080865862024-01-012024-12-3108086586bus:SmallEntities2025-01-012025-12-3108086586bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3108086586bus:FullAccounts2025-01-012025-12-3108086586bus:PrivateLimitedCompanyLtd2025-01-012025-12-3108086586core:WithinOneYear2025-12-3108086586core:AfterOneYear2025-12-3108086586core:WithinOneYear2024-12-3108086586core:AfterOneYear2024-12-3108086586core:ShareCapital2025-12-3108086586core:SharePremium2025-12-3108086586core:RevaluationReserve2025-12-3108086586core:OtherReservesSubtotal2025-12-3108086586core:RetainedEarningsAccumulatedLosses2025-12-3108086586core:ShareCapital2024-12-3108086586core:SharePremium2024-12-3108086586core:RevaluationReserve2024-12-3108086586core:OtherReservesSubtotal2024-12-3108086586core:RetainedEarningsAccumulatedLosses2024-12-3108086586core:LandBuildings2025-12-3108086586core:PlantMachinery2025-12-3108086586core:Vehicles2025-12-3108086586core:FurnitureFittings2025-12-3108086586core:OfficeEquipment2025-12-3108086586core:NetGoodwill2025-12-3108086586core:IntangibleAssetsOtherThanGoodwill2025-12-3108086586core:ListedExchangeTraded2025-12-3108086586core:UnlistedNon-exchangeTraded2025-12-3108086586core:LandBuildings2024-12-3108086586core:PlantMachinery2024-12-3108086586core:Vehicles2024-12-3108086586core:FurnitureFittings2024-12-3108086586core:OfficeEquipment2024-12-3108086586core:NetGoodwill2024-12-3108086586core:IntangibleAssetsOtherThanGoodwill2024-12-3108086586core:ListedExchangeTraded2024-12-3108086586core:UnlistedNon-exchangeTraded2024-12-3108086586core:LandBuildings2025-01-012025-12-3108086586core:PlantMachinery2025-01-012025-12-3108086586core:Vehicles2025-01-012025-12-3108086586core:FurnitureFittings2025-01-012025-12-3108086586core:OfficeEquipment2025-01-012025-12-3108086586core:NetGoodwill2025-01-012025-12-3108086586core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3108086586core:ListedExchangeTraded2025-01-012025-12-3108086586core:UnlistedNon-exchangeTraded2025-01-012025-12-3108086586core:MoreThanFiveYears2025-01-012025-12-3108086586core:Non-currentFinancialInstruments2025-12-3108086586core:Non-currentFinancialInstruments2024-12-3108086586dpl:CostSales2025-01-012025-12-3108086586dpl:DistributionCosts2025-01-012025-12-3108086586core:LandBuildings2025-01-012025-12-3108086586core:PlantMachinery2025-01-012025-12-3108086586core:Vehicles2025-01-012025-12-3108086586core:FurnitureFittings2025-01-012025-12-3108086586core:OfficeEquipment2025-01-012025-12-3108086586dpl:AdministrativeExpenses2025-01-012025-12-3108086586core:NetGoodwill2025-01-012025-12-3108086586core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3108086586dpl:GroupUndertakings2025-01-012025-12-3108086586dpl:ParticipatingInterests2025-01-012025-12-3108086586dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3108086586core:ListedExchangeTraded2025-01-012025-12-3108086586dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3108086586core:UnlistedNon-exchangeTraded2025-01-012025-12-3108086586dpl:CostSales2024-01-012024-12-3108086586dpl:DistributionCosts2024-01-012024-12-3108086586core:LandBuildings2024-01-012024-12-3108086586core:PlantMachinery2024-01-012024-12-3108086586core:Vehicles2024-01-012024-12-3108086586core:FurnitureFittings2024-01-012024-12-3108086586core:OfficeEquipment2024-01-012024-12-3108086586dpl:AdministrativeExpenses2024-01-012024-12-3108086586core:NetGoodwill2024-01-012024-12-3108086586core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3108086586dpl:GroupUndertakings2024-01-012024-12-3108086586dpl:ParticipatingInterests2024-01-012024-12-3108086586dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3108086586core:ListedExchangeTraded2024-01-012024-12-3108086586dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3108086586core:UnlistedNon-exchangeTraded2024-01-012024-12-3108086586core:NetGoodwill2025-12-3108086586core:IntangibleAssetsOtherThanGoodwill2025-12-3108086586core:LandBuildings2025-12-3108086586core:PlantMachinery2025-12-3108086586core:Vehicles2025-12-3108086586core:FurnitureFittings2025-12-3108086586core:OfficeEquipment2025-12-3108086586core:AfterOneYear2025-12-3108086586core:WithinOneYear2025-12-3108086586core:ListedExchangeTraded2025-12-3108086586core:UnlistedNon-exchangeTraded2025-12-3108086586core:ShareCapital2025-12-3108086586core:SharePremium2025-12-3108086586core:RevaluationReserve2025-12-3108086586core:OtherReservesSubtotal2025-12-3108086586core:RetainedEarningsAccumulatedLosses2025-12-3108086586core:NetGoodwill2024-12-3108086586core:IntangibleAssetsOtherThanGoodwill2024-12-3108086586core:LandBuildings2024-12-3108086586core:PlantMachinery2024-12-3108086586core:Vehicles2024-12-3108086586core:FurnitureFittings2024-12-3108086586core:OfficeEquipment2024-12-3108086586core:AfterOneYear2024-12-3108086586core:WithinOneYear2024-12-3108086586core:ListedExchangeTraded2024-12-3108086586core:UnlistedNon-exchangeTraded2024-12-3108086586core:ShareCapital2024-12-3108086586core:SharePremium2024-12-3108086586core:RevaluationReserve2024-12-3108086586core:OtherReservesSubtotal2024-12-3108086586core:RetainedEarningsAccumulatedLosses2024-12-3108086586core:NetGoodwill2023-12-3108086586core:IntangibleAssetsOtherThanGoodwill2023-12-3108086586core:LandBuildings2023-12-3108086586core:PlantMachinery2023-12-3108086586core:Vehicles2023-12-3108086586core:FurnitureFittings2023-12-3108086586core:OfficeEquipment2023-12-3108086586core:AfterOneYear2023-12-3108086586core:WithinOneYear2023-12-3108086586core:ListedExchangeTraded2023-12-3108086586core:UnlistedNon-exchangeTraded2023-12-3108086586core:ShareCapital2023-12-3108086586core:SharePremium2023-12-3108086586core:RevaluationReserve2023-12-3108086586core:OtherReservesSubtotal2023-12-3108086586core:RetainedEarningsAccumulatedLosses2023-12-3108086586core:AfterOneYear2025-01-012025-12-3108086586core:WithinOneYear2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3108086586core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3108086586core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3108086586core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3108086586core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3108086586core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3108086586core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3108086586core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3108086586core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3108086586core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3108086586core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3108086586core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3108086586bus:Director12025-01-012025-12-3108086586bus:Director22025-01-012025-12-3108086586bus:Director32025-01-012025-12-3108086586bus:Director42025-01-012025-12-31

KITE INSIGHTS LIMITED

Registered Number
08086586
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

KITE INSIGHTS LIMITED
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

BRET STERN, Laurence Marie
LAMBIN, Sophie Marie Daniele
STOPFORD SACKVILLE, Ela Lucinda
VAIDYA, Parag, Mr.

Registered Address

2 Vardens Road
London
SW11 1RH

Registered Number

08086586 (England and Wales)
KITE INSIGHTS LIMITED
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3482,040483,577
Tangible assets4318634
482,358484,211
Current assets
Debtors5537,125738,706
Cash at bank and on hand419,405263,881
956,5301,002,587
Creditors amounts falling due within one year6(1,059,382)(1,080,465)
Net current assets (liabilities)(102,852)(77,878)
Total assets less current liabilities379,506406,333
Creditors amounts falling due after one year7(303,069)(299,793)
Net assets76,437106,540
Capital and reserves
Called up share capital324324
Share premium2,014,9052,014,905
Profit and loss account(1,938,792)(1,908,689)
Shareholders' funds76,437106,540
The financial statements were approved and authorised for issue by the Board of Directors on 23 April 2026, and are signed on its behalf by:
LAMBIN, Sophie Marie Daniele
Director
Registered Company No. 08086586
KITE INSIGHTS LIMITED
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Judgements and key sources of estimation uncertainty
In the application of the company's accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying values of assets and liabilities that are not readily apparent from other sources. These critical accounting judgements and estimations are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates. The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods. The critical judgements made by management that have a significant effect on the amounts recognised in the financial statements are described below.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Research and development
All research costs are expensed. Costs related to the development of products are capitalised when they meet the criteria stated in FRS 102, Section 18 Intangible assets other than Goodwill. All other development expenditure is recognised as an expense in the period in which it is incurred.
Development costs
Capitalised development costs are stated at cost less accumulated amortisation and accumulated impairment losses (cost model). Amortisation is recognised using the straight-line basis and results in the carrying amount being expensed in profit or loss over the estimated useful life.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:
Impairment of non-financial assets policy
Assets which are not carried at fair value are reviewed for evidence of impairment at each reporting date. Where the asset is showing indicators of impairment, the recoverable amount of the asset, is estimated and then compared to the carrying value in the financial statements. Where the carrying amount is in excess of recoverable amount, an impairment loss is recognised in profit or loss.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Financial instruments
A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit and loss. All other investments are subsequently measured at cost less impairment. Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment.
Government grants or assistance
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
2.Average number of employees

20252024
Average number of employees during the year2328
3.Intangible assets

Other

Total

££
Cost or valuation
At 01 January 251,108,5871,108,587
Additions341,826341,826
At 31 December 251,450,4131,450,413
Amortisation and impairment
At 01 January 25625,010625,010
Charge for year343,363343,363
At 31 December 25968,373968,373
Net book value
At 31 December 25482,040482,040
At 31 December 24483,577483,577
4.Tangible fixed assets

Plant & machinery

Total

££
Cost or valuation
At 01 January 251,5831,583
At 31 December 251,5831,583
Depreciation and impairment
At 01 January 25949949
Charge for year316316
At 31 December 251,2651,265
Net book value
At 31 December 25318318
At 31 December 24634634
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables323,529409,483
Amounts owed by group undertakings-6,843
Other debtors31,08716,709
Prepayments and accrued income182,509305,671
Total537,125738,706
Accrued income was £113,634 (2025) and £129,567 (2024) of the above Prepayments and accrued income balances.
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables112,91376,515
Bank borrowings and overdrafts20,00624,042
Amounts owed to related parties405-
Taxation and social security164,26079,959
Other creditors128,204152,139
Accrued liabilities and deferred income633,594747,810
Total1,059,3821,080,465
Deferred income was £417,176 (2025) and £478,681 (2024) of the above Accrued liabilies and deferred income balances
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts3,33419,308
Convertible loans299,735280,485
Total303,069299,793
Convertible loan notes amounting to £275,000 were issued in September 2024.
8.Related party transactions
During the year the company entered into the following transactions with related parties: There was a balance of £405.13 due to the USA branch (2024: £6,843 due from the USA branch.)
9.Further information regarding the company's financial position
Included in Other Creditors, due within one year, is a loan account with director Sophie Marie Daniele Lambin of £115,585 (2024: £129,104).